v3.26.3
Reportable Segment Information - Summary of Financial Information for Each Reportable Segment (Parenthetical) (Details) - USD ($)
12 Months Ended
Jul. 01, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Income (loss) on acquisitions and divestitures   $ (8,000,000) $ (161,000,000) $ (115,000,000)
Foreign currency cumulative translation adjustment   (3,000,000) (46,000,000) (53,000,000)
Goodwill impairment $ 0 0 706,000,000 0
Accelerated depreciation   5,000,000 41,000,000 57,000,000
Avoca [Member]        
Segment Reporting Information [Line Items]        
Income (loss) on acquisitions and divestitures   3,000,000 8,000,000  
Impairment charge     183,000,000  
Nutraceuticals [Member]        
Segment Reporting Information [Line Items]        
Income (loss) on acquisitions and divestitures       (8,000,000)
Impairment charge       99,000,000
Life Sciences [Member]        
Segment Reporting Information [Line Items]        
Goodwill impairment     375,000,000  
Capital project impairment   16,000,000    
Accelerated depreciation     21,000,000  
Specialty Additives [Member]        
Segment Reporting Information [Line Items]        
Goodwill impairment     331,000,000  
Capital project impairment   2,000,000    
Accelerated depreciation   3,000,000 19,000,000 55,000,000
Personal Care [Member]        
Segment Reporting Information [Line Items]        
Capital project impairment       11,000,000
Accelerated depreciation   1,000,000 $ 1,000,000 $ 2,000,000
Unallocated and Other [Member]        
Segment Reporting Information [Line Items]        
Excess land contract termination fee income   2,000,000    
Foreign currency cumulative translation adjustment   13,000,000    
Accelerated depreciation   $ 1,000,000